| A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis TE King Jr, WZ Bradford, S Castro-Bernardini, EA Fagan, I Glaspole, ... New England journal of medicine 370 (22), 2083-2092, 2014 | 3755 | 2014 |
| International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for … JB Orens, M Estenne, S Arcasoy, JV Conte, P Corris, JJ Egan, T Egan, ... The Journal of heart and lung transplantation 25 (7), 745-755, 2006 | 1262 | 2006 |
| Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis CJ Lettieri, SD Nathan, SD Barnett, S Ahmad, AF Shorr Chest 129 (3), 746-752, 2006 | 981 | 2006 |
| Pulmonary hypertension in chronic lung disease and hypoxia SD Nathan, JA Barbera, SP Gaine, S Harari, FJ Martinez, H Olschewski, ... European Respiratory Journal 53 (1), 2019 | 573 | 2019 |
| Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial G Raghu, J Behr, KK Brown, JJ Egan, SM Kawut, KR Flaherty, FJ Martinez, ... Annals of internal medicine 158 (9), 641-649, 2013 | 538 | 2013 |
| Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials PW Noble, C Albera, WZ Bradford, U Costabel, RM Du Bois, EA Fagan, ... European Respiratory Journal 47 (1), 243-253, 2016 | 473 | 2016 |
| Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant AF Shorr, JL Wainright, CS Cors, CJ Lettieri, SD Nathan European Respiratory Journal 30 (4), 715-721, 2007 | 410 | 2007 |
| Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium SD Nathan, OA Shlobin, N Weir, S Ahmad, JM Kaldjob, E Battle, ... Chest 140 (1), 221-229, 2011 | 383 | 2011 |
| Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease A Waxman, R Restrepo-Jaramillo, T Thenappan, A Ravichandran, ... New England Journal of Medicine 384 (4), 325-334, 2021 | 355 | 2021 |
| Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics AF Shorr, DL Helman, DB Davies, SD Nathan European Respiratory Journal 25 (5), 783-788, 2005 | 336 | 2005 |
| Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β RM Kottmann, AA Kulkarni, KA Smolnycki, E Lyda, T Dahanayake, ... American journal of respiratory and critical care medicine 186 (8), 740-751, 2012 | 322 | 2012 |
| Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis SD Nathan, C Albera, WZ Bradford, U Costabel, I Glaspole, MK Glassberg, ... The Lancet Respiratory Medicine 5 (1), 33-41, 2017 | 313 | 2017 |
| Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis SD Nathan, OA Shlobin, S Ahmad, S Urbanek, SD Barnett Chest 131 (3), 657-663, 2007 | 308 | 2007 |
| Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots SD Nathan, PW Noble, RM Tuder American journal of respiratory and critical care medicine 175 (9), 875-880, 2007 | 274 | 2007 |
| Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension L Chan, LMK Chin, M Kennedy, JG Woolstenhulme, SD Nathan, ... Chest 143 (2), 333-343, 2013 | 270 | 2013 |
| Predicting mortality in patients with sarcoidosis awaiting lung transplantation AF Shorr, DB Davies, SD Nathan Chest 124 (3), 922-928, 2003 | 264 | 2003 |
| Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis SD Nathan, OA Shlobin, SD Barnett, R Saggar, JA Belperio, DJ Ross, ... Respiratory medicine 102 (9), 1305-1310, 2008 | 247 | 2008 |
| Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis SD Nathan, OA Shlobin, S Ahmad, J Koch, SD Barnett, N Ad, N Burton, ... Respiration 76 (3), 288-294, 2008 | 244 | 2008 |
| Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension AA Weinstein, LMK Chin, RE Keyser, M Kennedy, SD Nathan, ... Respiratory medicine 107 (5), 778-784, 2013 | 217 | 2013 |
| Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis LH Lancaster, JA de Andrade, JD Zibrak, ML Padilla, C Albera, ... European respiratory review 26 (146), 2017 | 210 | 2017 |
